检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李勋[1] 牛德云[1] 康延申[1] 郝彦玲[1] 张其程[1] 何彦平[1] 孙红岩[1] 邵一鸣 齐智[1]
机构地区:[1]中国疾病预防控制中心性病艾滋病预防控制中心,北京102206
出 处:《中国热带医学》2013年第10期1173-1176,共4页China Tropical Medicine
基 金:国家十二五科技重大专项-艾滋病和病毒性肝炎等重大传染病防治-DNA疫苗(No.2012ZX10001008-012);传染病预防控制国家重点实验室留学归国人员项目资助(No.2012SKLID402)
摘 要:目的构建表达中国流行株HIV-1 CRF_07 B/C亚型(CN54)膜蛋白gp140及其突变体,为HIV-1疫苗设计提供优秀的免疫原。方法构建gp140、gp140 ST质粒,将质粒瞬时转染293F细胞,120h后收获上清液,经纯化、浓缩、PBS置换后,利用SDS-PAGE电泳、Western-blot检测蛋白的表达,ELISA检测其与HIV-1阳性病人血清的反应性。结果 SDS-PAGE电泳、Western-blot试验证明成功表达了gp140、gp140 ST蛋白,并且gp140 ST是一个稳定的三聚体蛋白质。ELISA试验检测,发现表达的gp140 ST蛋白与HIV-1阳性病人血清的亲和力高于gp140蛋白。结论经过突变改造的gp140 ST具有稳定的三聚体构象,可作为HIV-1免疫原进行疫苗研究。Abstract:Objective To construct the recombinant plasmid that for express gpl40 of HIV-1 CRF_07 subtypes B/C (CN54) and the mutations,two amino acids on gp140 protein was mutated through Q567K and K588R,named gp140 ST in order to make the gp140 become stable trimer conformation produced to be used as a candidate of HIV-1 vaccine. Methods HIV-1 gp140 and gp140 ST plasmids were concstructed by PCR technology. Recombinant plasmids of gp140 and gpl40 ST were transfected into 293F cells,respectively,and the supematants were collected 120 hours after transfection. After purified and concentrated,the proteins of gpl40 and gpl40 ST were identified by SDS-PAGE,Westem-blot,and ELISA were performed to analyze and determine the bioreactivity of the gpl40 and gpl40 ST proteins. Results SDS-PAGE,westem-blot suggested that gpl40 ST was a stable trimer compared with gpl40. ELISA indicated that the recombinant proteins of gp140 ST could strongy bind with the sera of Chinese HIV-1 positive patients than that with gpl40. Conclusions Gpl40 ST trimer was more stable with more immunogenic and can be an excellent immunogen for HIV-1 vaccine design.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.191.175.60